 |
15 Diseases |  |
3 Trials |
|
3 Trials |  |
350 News |  |
| «1234 |
- zolmitriptan inhalational (CVT-427) / Acorda
Enrollment closed: Safety and Pharmacokinetics (PK) Study of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults (clinicaltrials.gov) - Feb 4, 2016
P1, N=32, Active, not recruiting, Sponsor: Acorda Therapeutics
Recruiting --> Active, not recruiting
- | zolmitriptan inhalational (CVT-427) / Acorda
New P1 trial: Safety and Pharmacokinetics (PK) Study of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults (clinicaltrials.gov) - Nov 21, 2015
P1, N=32, Recruiting, Sponsor: Acorda Therapeutics
- || sumatriptan/naproxen / Generic mfg.
Trial primary completion date: TRXvUsualTrptn: Does Treximet Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response? (clinicaltrials.gov) - Feb 6, 2015
P4, N=60, Recruiting, Sponsor: The Cleveland Clinic
Recruiting --> Active, not recruiting Trial primary completion date: Dec 2014 --> Dec 2016
- || sumatriptan/naproxen / Generic mfg.
Trial primary completion date: TRXvUsualTrptn: Does Treximet Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response? (clinicaltrials.gov) - Jun 27, 2014
P4, N=60, Recruiting, Sponsor: The Cleveland Clinic
Trial primary completion date: Dec 2014 --> Dec 2016 Trial primary completion date: Jun 2014 --> Dec 2014
- ||| zolmitriptan / Generic mfg.
Enrollment change: TEENZ: Zomig - Treatment of Acute Migraine Headache in Adolescents (clinicaltrials.gov) - Jan 14, 2014
P4, N=1653, Completed, Sponsor: AstraZeneca
Trial primary completion date: Jun 2014 --> Dec 2014 N=2400 --> 1653
- |||| zolmitriptan / Generic mfg.
Trial completion: TEENZ: Zomig - Treatment of Acute Migraine Headache in Adolescents (clinicaltrials.gov) - Jan 14, 2014
P4, N=1653, Completed, Sponsor: AstraZeneca
N=2400 --> 1653 Active, not recruiting --> Completed
- ||||| telcagepant (MK-0974) / Merck (MSD)
Enrollment change: Study of Telcagepant (MK-0974) in Participants With Moderate to Severe Acute Migraine With or Without Aura (MK-0974-011) (clinicaltrials.gov) - Nov 24, 2013
P3, N=1380, Completed, Sponsor: Merck Sharp & Dohme Corp.
Active, not recruiting --> Completed N=1800 --> 1380
- sumatriptan/naproxen / Generic mfg., naproxen / Generic mfg.
Real-world evidence, Real-world: A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data (clinicaltrials.gov) - Feb 20, 2013
P=N/A, N=1, Completed, Sponsor: GlaxoSmithKline
N=1800 --> 1380 Active, not recruiting --> Completed
- zolmitriptan / Generic mfg.
Trial completion: Effects of Zolmitriptan on Sensory Transmission After Spinal Cord Injury (clinicaltrials.gov) - Nov 29, 2012
P=N/A, N=13, Completed, Sponsor: University of Alberta
Active, not recruiting --> Completed Active, not recruiting --> Completed
- sumatriptan/naproxen / Generic mfg., naproxen / Generic mfg.
Monotherapy: Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy (clinicaltrials.gov) - Aug 22, 2012
P=N/A, N=1, Completed, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Active, not recruiting --> Completed